M. Driesman

Strategies for drug‐eluting stent treatment of bifurcation coronary artery disease in the United States: Insights from the e‐Cypher S.T.L.L.R.Trial

D. Angiolillo, H. Bezerra, M. Tannenbaum, 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Bivalirudin versus unfractionated heparin during percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndrome initially treated with fondaparinux: results from an international, multicenter, randomized pilot study (SWITCH III).

S. Mehta, D. Dvir, R. Torguson, 2013, Journal of interventional cardiology.

Abstract 2563: Impact of Type of Longitudinal Geographical Miss on Clinical Outcome after Sirolimus-eluing Stent Implantation: Insights from The STLLR Trial

M. Tannenbaum, M. Bikkina, M. Costa, 2008 .

Acquired Coronary Cameral Fistula Due to Post Stent Balloon Dilatation: Dual Coronary Artery Perforations into the Left Ventricle—What Is the Right Treatment?

Arti Singh, M. Driesman, A. Murthy, 2014 .

Inhibition of human erythrocytic adenosine deaminase by coformycin studies with the isolated enzyme and the intact cells

R. Parks, R. Agarwal, M. Driesman, 1974 .

Impact of stent deployment procedural factors on long-term effectiveness and safety of sirolimus-eluting stents (final results of the multicenter prospective STLLR trial).

Theodore A Bass, D. Angiolillo, M. Tannenbaum, 2008, The American journal of cardiology.